FDA Label for Subleef Numbing
View Indications, Usage & Precautions
Subleef Numbing Product Label
The following document was submitted to the FDA by the labeler of this product Jiangxi Yudexi Pharmaceutical Co., Ltd. The document includes published materials associated whith this product with the essential scientific information about this product as well as other prescribing information. Product labels may durg indications and usage, generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, warnings, inactive ingredients, etc.
Active Ingredient
Lidocaine 4%
Purpose
Local Anesthetic
Use
For the temporary relief of pain and itching associated with minor burns, sunburn, insect bites and minor skin irritations
Warnings
·For external use only. ·If condition worsens, or if symptoms persist for more than 7 days or clear up and occur again within a few days, discontinue use of this product and consult a doctor
Do Not Use
·Do not use in large quantities, particularly over raw surfaces or blistered areas
When Using
·Avoid contact with eyes, lf this happens, rinse thoroughly with water.
Stop Use
·Condition worsens or does not improve within 7 days.·Allergic reaction occurs to ingredients in this product.·Symptom being treated does not subside or if redness, irritation
Ask Doctor
·Condition worsens or does not improve within 7 days.·Allergic reaction occurs to ingredients in this product.·Symptom being treated does not subside or if redness, irritation
Keep Oot Of Reach Of Children
If pregnant or breast-feeding, ask a health professional before use
Directions
Adults and children 2 years of age and older.Apply to affected area not more than 3 to 4 times daily.Children under 2 years of age: Do not use, consult a doctor
Other Information
Store between 15-30℃(59-86F). Avoid freezing and excessive heat above 40 ℃(104°F).
Inactive Ingredients
Water,Carbomer934, propylene Glycol,soybean Lecithin,.Alpha.-Tocopherol Acetate,Benzyl Alcohol.
Principal Display Panel
* Please review the disclaimer below.
